126 related articles for article (PubMed ID: 9210165)
1. Neuropeptide K and neurokinin A stimulate CRH and ACTH release by rat adrenal medulla in vitro.
Mazzocchi G; Malendowicz LK; Gottardo G; Nussdorfer GG
Peptides; 1997; 18(4):487-90. PubMed ID: 9210165
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin stimulates CRH and ACTH release by rat adrenal medulla in vitro.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo G; Nussdorfer GG
Neuropeptides; 1997 Feb; 31(1):8-11. PubMed ID: 9574829
[TBL] [Abstract][Full Text] [Related]
3. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis.
Nussdorfer GG; Malendowicz LK
Peptides; 1998; 19(5):949-68. PubMed ID: 9663462
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide K enhances glucocorticoid release by acting directly on the rat adrenal gland: the possible involvement of zona medullaris.
Mazzocchi G; Malendowicz LK; Andreis PG; Meneghelli V; Markowska A; Belloni AS; Nussdorfer GG
Brain Res; 1994 Oct; 661(1-2):91-6. PubMed ID: 7834390
[TBL] [Abstract][Full Text] [Related]
5. Arginine-vasopressin stimulates CRH and ACTH release by rat adrenal medulla, acting via the V1 receptor subtype and a protein kinase C-dependent pathway.
Mazzocchi G; Malendowicz LK; Rebuffat P; Tortorella C; Nussdorfer GG
Peptides; 1997; 18(2):191-5. PubMed ID: 9149290
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide gamma.
Debeljuk L; Lasaga M
Peptides; 1999; 20(2):285-99. PubMed ID: 10422885
[TBL] [Abstract][Full Text] [Related]
7. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ.
Jansen I; Alafaci C; McCulloch J; Uddman R; Edvinsson L
J Cereb Blood Flow Metab; 1991 Jul; 11(4):567-75. PubMed ID: 1711051
[TBL] [Abstract][Full Text] [Related]
8. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
Kalra PS; Sahu A; Bonavera JJ; Kalra SP
Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
[TBL] [Abstract][Full Text] [Related]
9. Effects of tachykinins on luteinizing hormone release in female rats: potent inhibitory action of neuropeptide K.
Sahu A; Kalra SP
Endocrinology; 1992 Mar; 130(3):1571-7. PubMed ID: 1371455
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.
Arai H; Emson PC
Brain Res; 1986 Dec; 399(2):240-9. PubMed ID: 2435360
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation.
Couture R; Picard P; Poulat P; Prat A
Can J Physiol Pharmacol; 1995 Jul; 73(7):892-902. PubMed ID: 8846427
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Markowska A; Nussdorfer GG
Mol Cell Neurosci; 1994 Aug; 5(4):345-9. PubMed ID: 7804604
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide K stimulates corticosterone release in the rat.
Kalra PS; Kalra SP
Brain Res; 1993 May; 610(2):330-3. PubMed ID: 8391371
[TBL] [Abstract][Full Text] [Related]
15. Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.
Martling CR; Theodorsson-Norheim E; Norheim I; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):183-9. PubMed ID: 2825041
[TBL] [Abstract][Full Text] [Related]
16. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
Bierwolf C; Burgemeister A; Lüthke K; Born J; Fehm HL
J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
[TBL] [Abstract][Full Text] [Related]
17. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
[TBL] [Abstract][Full Text] [Related]
18. Dual capsaicin effects on ureteric motility: low dose inhibition mediated by calcitonin gene-related peptide and high dose stimulation by tachykinins?
Hua XY; Lundberg JM
Acta Physiol Scand; 1986 Nov; 128(3):453-65. PubMed ID: 2431598
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex: evidence for an indirect action requiring the presence of the zona medullaris.
Malendowicz LK; Andreis PG; Markowska A; Nowak M; Warchol JB; Neri G; Nussdorfer GG
Res Exp Med (Berl); 1994; 194(2):69-79. PubMed ID: 8059061
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin A, neurokinin B and neuropeptide K in the rabbit iris: a study comparing different extraction methods.
Beding-Barnekow B; Brodin E
Regul Pept; 1989 May; 25(2):199-206. PubMed ID: 2547226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
